BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12660284)

  • 1. Macroprolactinaemia associated with prolactin adenoma.
    Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
    Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of macroprolactinaemia.
    Hattori N; Adachi T; Ishihara T; Shimatsu A
    Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
    Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological features of patients with macroprolactinaemia.
    Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
    Olukoga AO; Kane JW
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of macroprolactin by precipitation and ultrafiltration methods.
    Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
    Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
    Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroprolactin: what is it and what is its importance?
    Sadideen H; Swaminathan R
    Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
    Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical method for the detection of macroprolactinaemia using ultrafiltration.
    Prazeres S; Santos MA; Ferreira HG; Sobrinho LG
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):686-90. PubMed ID: 12780743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolactin variants in serum and amniotic fluid of women with ovulatory hyperprolactinemia].
    Larrea F; Escorza A; Méndez I; Ruiz JE; Valero A; Cravioto MC
    Rev Invest Clin; 1991; 43(3):245-51. PubMed ID: 1818370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.